When one of Rhode Island’s most-wanted fugitives was discovered last week to have been secretly working under an alias in the biotech industry, the reaction among...
Biotechs bring big launches and pharma rivalries into Q2 earnings period
Nature Biotechnology, Published online: 29 July 2026; doi:10.1038/s41587-026-03251-9 As biotechnology becomes one of the defining technologies that will shape economic strength, national resilience and geopolitical influence...
The expulsion of five diabetes experts from the American Diabetes Association meeting last month continues to reverberate, with more than 200 members now calling for two...
Drug discovery teams have more data than ever, but turning that data into actionable insight remains a major challenge. In this candid conversation, Patsnap’s Ben Coverdale...
Argenx has agreed to acquire Forte Biosciences for $2.2 billion, the companies said, in a deal intended to expand the buyer’s immunology portfolio with an early...
WASHINGTON — Senate Republicans, and particularly Rand Paul (R-Ky.), have long been critical of the government’s actions during the Covid-19 pandemic — which began during the...
For nearly half a century, the federal government encouraged international students and scholars to study in the U.S. by allowing them to stay for the duration...
Nova Biomedical acquired certain assets of NanoCellect, which develops microfluidic cell sorting technology, to expand its capabilities in cell line development and strengthen support for biopharmaceutical...
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your...